Qingrejiedu Lipids And C-reactive Protein In Patients With Coronary Heart Disease Clinical Research

Object The purpose of this subject in the western standard treatment on the basis ofapplication Qingrejiedu Chinese medicine preparations, Western medicine alone withthe crowd for a comparative analysis, Observation Qingrejiedu Chinese agents onpatients with coronary heart disease and low-density lipoprotein cholesterol (LDL-C) inthe lipid composition and inflammatory response China plays an important role in thefactor C-reactive protein (CRP) expression, China aims to medical applicationsQingrejiedu to control atherosclerosis (AS) for the clinical application on the basis ofobjective and effect Evaluation criteria for the prevention AS seek new and effectiveways. AS explore and lipid metabolism disorders and inflammatory response, and thesearch for common control, to further explore the pathogenesis of AS from thetheoretical and clinical medicine which enrich the understanding of AS.Methods 40 cases of coronary angiography in the diagnosis of coronary heartdisease were randomly divided into two groups. Western standards in the treatment ofcoronary artery disease on the basis of the observation group Qingrejiedu use ofChinese herbal medicine and the control group, fluvastatin. Detection AS predictors ofserum total cholesterol (TC), high density lipoprotein cholesterol (HDL), low-densitylipoprotein cholesterol (LDL-C), C-reactive protein (CRP), and other indicators.Outpatient treatment for the same 20 healthy subjects were healthy control group.Results Results of a 2 treatment group BMI level than before treatment (P＜0.05)After treatment, body mass index to compare the difference was not significant (P＞0.05). Note homemade medicine with statins have a role in weight reduction, but rathereffects. 2 for the treatment group after two TC LDL lower than before treatment (P＜0.05) After three treatment groups for LDL-C between the TC was no significantdifference, but it means, the control group than the observation group TC and LDL-Cdrop even lower. HDL control group after treatment than before (P＜0.05); HDL groupbefore and after treatment there was no significant difference. Three two CRP levelsafter treatment was significantly lower than before treatment (P＜0.01); observed aftertreatment CRP levels lower than the control group. Show Observer Group in loweringCRP better than the control group. Qingrejiedu suggest drug significantly lower CRPlevel. Conclusion This study shows that Qingrejiedu medicine and fluvastatin in patientswith coronary heart disease can reduce the body mass index, Note this medicine andStatins have to obesity treatment. Chinese and fluvastatin can be significantly reducedTC, LDL-C, but the conventional dose fluvastatin role better. 2 treatment group CRPlevel was significantly lower than before treatment, the Observer Group in loweringCRP compatibility is superior to the control group. Qingrejiedu suggested Chinesemedicine is significantly lower CRP level.